Chris Wilkinson, head of sales for Healthcare for Siemens Financial Services in the UK, looks at the value of new-generation digitalised technology within the pharmaceutical industry.
Narasimharaju SN, senior manager — regulatory affairs and Mac Kella, senior regulatory affairs executive at ELC Group assess whether biosimilars are really interchangeable in the EU.
Companies are putting themselves at risk by failing to appropriately prioritise and resource compliance. Here, specialist risk consultancy, Control Risks, discusses its annual research report into business attitudes towards legal and compliance risk.
The UK’s separation from the EU could have implications for regulatory harmonisation, and increase administrative workloads at a time when responsible teams are already overstretched and experienced talent is hard to find.
How do managers in the pharmaceutical industry ensure that their plant performs reliably and safely? Michael Dixey and Pete Hibbs of GGR Associates explain some of the reasons for poor performance and suggest how these problems may be overcome.
‘Last mile’ transportation and subsequent user storage conditions present unique challenges when it comes to ensuring the safe and effective use of pharmaceutical products.
The potential benefits of genomics are well documented in healthcare, European Pharmaceutical Manufacturer reporter Reece Armstrong examines the latest developments in the field.
Global provider of auto-ID solutions, SATO, has published a white paper looking at the role of traceability in a digital world and its role in competitiveness.
